Skip to main content
Erschienen in: Calcified Tissue International 4/2014

01.10.2014 | Original Research

Osteoporosis and the Risk of Symptomatic Nephrolithiasis: A Population-Based 5-Year Follow-Up Study in Taiwan

verfasst von: Ping-Song Chou, Chun-Nan Kuo, Kuo-Sheng Hung, Wei-Chiao Chang, Yu-Chien Liao, Ying-Chen Chi, Wei-Po Chou, Shih-Jen Tsai, Mu-En Liu, Chiou-Lian Lai, Yii-Her Chou, Wei-Pin Chang

Erschienen in: Calcified Tissue International | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

This study estimates the risk of symptomatic nephrolithiasis within 5 years of newly diagnosed osteoporosis in a Taiwan population. This cohort study consisted of patients with a diagnosis of osteoporosis between Jan. 2003 and Dec. 2005 (N = 1634). Four age- and gender- matched patients for every patient in the study cohort were selected using random sampling as the comparison cohort (N = 6536). All patients were tracked for 5 years from the date of cohort entry to identify whether they developed symptomatic nephrolithiasis. Cox proportional hazard regressions were performed to evaluate the 5-year nephrolithiasis-free survival rates. During the 5-year follow-up period, 60 osteoporosis patients (3.7 %) and 165 non- osteoporosis patients (2.5 %) developed symptomatic nephrolithiasis. The adjusted HR of symptomatic nephrolithiasis was 1.38 times greater risk for patients with osteoporosis than for the comparison cohort (95% confidence interval (CI) 1.03–1.86; P < .05). Osteoporosis is very likely to be an independent risk factor for subsequent diagnosis of symptomatic nephrolithiasis.
Literatur
1.
Zurück zum Zitat Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef
2.
Zurück zum Zitat Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America P (2012) Prevalence of kidney stones in the United States. Eur Urol 62:160–165PubMedCrossRefPubMedCentral Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America P (2012) Prevalence of kidney stones in the United States. Eur Urol 62:160–165PubMedCrossRefPubMedCentral
3.
Zurück zum Zitat Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79:393–403PubMedCrossRefPubMedCentral Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79:393–403PubMedCrossRefPubMedCentral
4.
Zurück zum Zitat Keller JJ, Lin CC, Kang JH, Lin HC (2013) Association between osteoporosis and urinary calculus: evidence from a population-based study. Osteoporos Int 24:651–657PubMedCrossRef Keller JJ, Lin CC, Kang JH, Lin HC (2013) Association between osteoporosis and urinary calculus: evidence from a population-based study. Osteoporos Int 24:651–657PubMedCrossRef
5.
Zurück zum Zitat Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S (2004) Osteoporosis and urolithiasis. Urol Int 72(1):17–19PubMedCrossRef Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S (2004) Osteoporosis and urolithiasis. Urol Int 72(1):17–19PubMedCrossRef
6.
Zurück zum Zitat Arrabal-Polo MA, Arrabal-Martin M, Giron-Prieto MS, Poyatos-Andujar A, Garrido-Gomez J, Zuluaga-Gomez A, Arias-Santiago S (2012) Osteopenia/osteoporosis in patients with calcium nephrolithiasis. Urol Res 40:709–716PubMedCrossRef Arrabal-Polo MA, Arrabal-Martin M, Giron-Prieto MS, Poyatos-Andujar A, Garrido-Gomez J, Zuluaga-Gomez A, Arias-Santiago S (2012) Osteopenia/osteoporosis in patients with calcium nephrolithiasis. Urol Res 40:709–716PubMedCrossRef
7.
Zurück zum Zitat Trinchieri A (2005) Bone mineral content in calcium renal stone formers. Urol Res 33:247–253PubMedCrossRef Trinchieri A (2005) Bone mineral content in calcium renal stone formers. Urol Res 33:247–253PubMedCrossRef
8.
Zurück zum Zitat Arrabal-Polo MA, Arrabal-Martin M, de Haro-Munoz T, Lopez-Leon VM, Merino-Salas S, Ochoa-Hortal MA, Garrido-Gomez J, Lahoz-Garcia C, Zuluaga-Gomez A (2011) Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int 108:1903–1908PubMedCrossRef Arrabal-Polo MA, Arrabal-Martin M, de Haro-Munoz T, Lopez-Leon VM, Merino-Salas S, Ochoa-Hortal MA, Garrido-Gomez J, Lahoz-Garcia C, Zuluaga-Gomez A (2011) Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int 108:1903–1908PubMedCrossRef
9.
Zurück zum Zitat Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 9:1525–1532PubMedCrossRef Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 9:1525–1532PubMedCrossRef
10.
Zurück zum Zitat Pietschmann F, Breslau NA, Pak CY (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383–1388PubMedCrossRef Pietschmann F, Breslau NA, Pak CY (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383–1388PubMedCrossRef
11.
Zurück zum Zitat Fuss M, Gillet C, Simon J, Vandewalle JC, Schoutens A, Bergmann P (1983) Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 9:32–34PubMed Fuss M, Gillet C, Simon J, Vandewalle JC, Schoutens A, Bergmann P (1983) Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 9:32–34PubMed
12.
Zurück zum Zitat Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G, Stefoni S (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260–266PubMed Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G, Stefoni S (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260–266PubMed
13.
Zurück zum Zitat Melton LJ 3rd, Crowson CS, Khosla S, Wilson DM, O’Fallon WM (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53:459–464PubMedCrossRef Melton LJ 3rd, Crowson CS, Khosla S, Wilson DM, O’Fallon WM (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53:459–464PubMedCrossRef
14.
Zurück zum Zitat Pasch A, Frey FJ, Eisenberger U, Mohaupt MG, Bonny O (2008) PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Nephrol Dial Transplant 23:2563–2570PubMedCrossRef Pasch A, Frey FJ, Eisenberger U, Mohaupt MG, Bonny O (2008) PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Nephrol Dial Transplant 23:2563–2570PubMedCrossRef
15.
Zurück zum Zitat Letavernier E, Traxer O, Daudon M, Tligui M, Hubert-Brierre J, Guerrot D, Sebag A, Baud L, Haymann JP (2011) Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol 6:1149–1154PubMedCrossRefPubMedCentral Letavernier E, Traxer O, Daudon M, Tligui M, Hubert-Brierre J, Guerrot D, Sebag A, Baud L, Haymann JP (2011) Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol 6:1149–1154PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat Reed BY, Heller HJ, Gitomer WL, Pak CY (1999) Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab 84:3907–3913PubMed Reed BY, Heller HJ, Gitomer WL, Pak CY (1999) Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab 84:3907–3913PubMed
18.
Zurück zum Zitat Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lemke M, Padalino P, Pak CY (2002) Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–1485PubMedCrossRef Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lemke M, Padalino P, Pak CY (2002) Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–1485PubMedCrossRef
Metadaten
Titel
Osteoporosis and the Risk of Symptomatic Nephrolithiasis: A Population-Based 5-Year Follow-Up Study in Taiwan
verfasst von
Ping-Song Chou
Chun-Nan Kuo
Kuo-Sheng Hung
Wei-Chiao Chang
Yu-Chien Liao
Ying-Chen Chi
Wei-Po Chou
Shih-Jen Tsai
Mu-En Liu
Chiou-Lian Lai
Yii-Her Chou
Wei-Pin Chang
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 4/2014
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-014-9895-y

Weitere Artikel der Ausgabe 4/2014

Calcified Tissue International 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.